Delisting Determination,The Nasdaq Stock Market, LLC,
March 14, 2017, Acura Pharmaceuticals, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Acura Pharmaceuticals, Inc.
(the Company), effective at the opening of the trading
session on March 24, 2017. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b). The Company was notified
of the Staffs determination on February 14, 2017.  The Company
did not appeal the Staff determination to the
Hearings Panel, and the Staff determination to delist the
Company became final on February 23, 2017.